SCHEMBL3871592

SCHEMBL3871592

c1ccc(-c2c(-c3ccccc3)n(-c3ccc(-c4ccc(-n5c(-c6ccccc6)c(-c6ccccc6)c6ccccc65)cc4)cc3)c3ccccc23)cc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ IL1R1 P14778 1/20 0.53
▸ KMT2A Q03164 4/20 0.51
▸ L3MBTL1 Q9Y468 2/20 0.51
▸ MEN1 O00255 2/20 0.51
▸ MAPT P10636 2/20 0.51
▸ ALDH1A1 P00352 2/20 0.51
▸ HTT P42858 1/20 0.51
▸ KDM4E B2RXH2 1/20 0.50
▸ ATM Q13315 1/20 0.50
▸ HDAC4 P56524 1/20 0.40
▸ HSP90AA1 P07900 1/20 0.39
▸ AGTR1 P30556 1/20 0.38
▸ ESR1 P03372 1/20 0.38
▸ ESR2 Q92731 1/20 0.38
▸ LMNA P02545 2/20 0.37
▸ FAAH O00519 1/20 0.36
▸ MGLL Q99685 1/20 0.36
▸ AVPR1A P37288 1/20 0.36
▸ SMN1; SMN2 Q16637 1/20 0.36
▸ CYP2C19 P33261 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9886117 0.96 L3MBTL1 (0.57) IL1R1KMT2AL3MBTL1MEN1MAPT
SCHEMBL3861644 0.96 L3MBTL1 (0.57) IL1R1KMT2AL3MBTL1MEN1MAPT
SCHEMBL18803097 0.96 IL1R1 (0.50) IL1R1KMT2AL3MBTL1MEN1MAPT
SCHEMBL18803095 0.95 IL1R1 (0.53) IL1R1KMT2AL3MBTL1MEN1MAPT
SCHEMBL18803081 0.95 IL1R1 (0.53) IL1R1KMT2AL3MBTL1MEN1MAPT
SCHEMBL18803075 0.95 IL1R1 (0.53) IL1R1KMT2AL3MBTL1MEN1MAPT
SCHEMBL18803046 0.94 IL1R1 (0.54) IL1R1KMT2AL3MBTL1MEN1MAPT
SCHEMBL18803005 0.94 IL1R1 (0.54) IL1R1KMT2AL3MBTL1MEN1MAPT
SCHEMBL18803077 0.93 IL1R1 (0.54) IL1R1KMT2AL3MBTL1MEN1MAPT
SCHEMBL18803043 0.93 IL1R1 (0.57) IL1R1KMT2AL3MBTL1MEN1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20190119258-A1 ORGANIC COMPOUND AND PHOTOELECTRIC CONVERSION ELEMENT CANON KABUSHIKI KAISHA (JP) 2019-04-25 — — US disclosed
US-7597955-B2 Light-emitting device, organic compound and display CANON KABUSHIKI KAISHA (JP) 2009-10-06 — — US disclosed
US-7597955-B2 Light-emitting device, organic compound and display CANON KABUSHIKI KAISHA (JP) 2009-10-06 — — US disclosed
US-7597955-B2 Light-emitting device, organic compound and display CANON KABUSHIKI KAISHA (JP) 2009-10-06 — — US disclosed
US-20070057250-A1 Light-emitting device, organic compound and display CANON KABUSHIKI KAISHA (JP) 2007-03-15 — — US disclosed
US-20070057250-A1 Light-emitting device, organic compound and display CANON KABUSHIKI KAISHA (JP) 2007-03-15 — — US disclosed
US-20070057250-A1 Light-emitting device, organic compound and display CANON KABUSHIKI KAISHA (JP) 2007-03-15 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190119258-A1 ORGANIC COMPOUND AND PHOTOELECTRIC CONVERSION ELEMENT SCN2B, MRPS22, CTNNA1 IL1R1 2523/4885KMT2A 1279/4885L3MBTL1 3849/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback